AACE Position Statement: Coronavirus (COVID-19) and People with Diabetes (Updated March 18, 2020)

COVID-19 is a novel coronavirus that can cause several symptoms, including fever, coughing, shortness of breath and difficulty breathing. As COVID-19 continues to spread in the United States, it is important for everyone to take the necessary precautions to help prevent infection and spread of the virus. Individuals over 60 years of age and those with pre-existing medical conditions, including diabetes, are at the highest risk for complications. Recent studies have shown that of those hospitalized for severe disease, 22.2% to 26.9% reported living with diabetes. Diabetes and high glucose… more

COVID-19 Resources: Telehealth, Updates and More

AACE is closely monitoring developments regarding COVID-19 and working with partner medical societies to provide information and resources to our members. Please refer to the links below: Telehealth Information Medicare will temporarily pay clinicians to provide telehealth services for beneficiaries across the entire country. Read more.… more

FDA Releases New Nutrition Facts Label for the First Time in 20 Years

Doctors, dietitians, and other health care professionals: The U.S. Food and Drug Administration has updated the Nutrition Facts label. The new label makes it easier for you and your clients to make informed food choices that contribute to lifelong healthy eating habits. Some of the changes include updated serving size information, Daily Values and nutrient listings, and calories and serving size information appearing in larger, bolder font. Learn about all the changes to the label to help your clients form healthier eating habits: www.fda.gov/… more

Insulin Manufacturing and Distribution Capabilities Currently Stable During COVID-19 Pandemic

At this time, the leading pharmaceutical manufacturers are reporting that COVID-19 is NOT having an impact on their manufacturing and distribution capabilities for insulin and other related supplies. Additionally, most local business restrictions and closures do not include pharmacies and grocery stores (many of which also contain pharmacies). People with diabetes are also expressing concerns about job loss and their ability to afford medication and supplies. Please use and share with your patients the following link to AACE’s online medication affordability resource, which provides a… more

AACE Position Statement: Coronavirus (COVID-19) and People with Adrenal Insufficiency and Cushing’s Syndrome

With the novel COVID-19 virus continuing to spread, it is crucial to adhere to the advice from experts and the Centers for Disease Control and Prevention (CDC) to help reduce risk of infection for individuals and the population at large. This is particularly important for people with adrenal insufficiency and people with uncontrolled Cushing’s Syndrome. Studies have reported that individuals with adrenal insufficiency… more

COVID-19 News: Industry Manufacturer Announces Insulin Savings Program

A new $35 co-pay is available through the Lilly Insulin Value Program in response to the COVID-19 crisis in the U.S.

In Memoriam: Alan J. Garber, MD, PhD, MACE

Dear colleagues, It is with great sadness that I share the news of Dr. Alan Garber’s passing yesterday on April 9, 2020. Dr. Garber was a Charter Member of AACE, as well as a Past President of both AACE and ACE. Over the years, Dr. Garber has been a well-known voice in our Endocrinology community. Since joining AACE in 1992, Dr. Garber had either served as a member or chair of multiple AACE and ACE committees – including writing committees for consensus statements, guidelines, algorithms, editorial boards, resource centers, and task forces. In 2005, he served as Co-Chair of the 14th… more

AACE Position Statement: Coronavirus (COVID-19) and People with Thyroid Disease

Although there is not yet enough information regarding the relationship between thyroid conditions and susceptibility to COVID-19, there is currently no reason to believe that most people with thyroid disease are at increased risk to contract this novel coronavirus or to experience complications. Nevertheless, if thyroid medications are not taken as prescribed, uncontrolled thyroid disease may increase a person’s risk for viral infection and complications. Additionally, immunosuppressive drugs, high-dose steroids and certain other treatments can increase a person’s risk for infections and… more

AACE Position Statement: Coronavirus (COVID-19) and People with Cardiometabolic Disease

Approximately 47 million Americans have some form of cardiometabolic disease, such as heart disease, strokes, peripheral arterial disease, type 2 diabetes, fatty liver disease, dyslipidemia and many other conditions. Accordingly, it is important to understand the relationship between COVID-19 and cardiometabolic disease. Initial research suggests that people with cardiometabolic disease are at increased risk of experiencing complications from infection with COVID-19 and may be more susceptible to contracting the virus. Studies indicate that up to 40% of hospitalized COVID-19 patients have… more

President/CEO Update to AACE Members – April 2020

Dear AACE members, We continue to think of you during this unprecedented season. While over the last several weeks you have received many helpful pieces of guidance, research, and news updates - today we simply wish to remind you that our priority remains to be you: our members. You are the heart of AACE, and you are our foremost thought that guides anything and everything we do. During these uncertain and challenging times, it is important for us all to continue to support and learn from each other – not just for us, but for our world and the communities we serve. With that in mind,… more